Edward Miller - Nov 14, 2022 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role
General Counsel
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Stock symbol
ALVR
Transactions as of
Nov 14, 2022
Transactions value $
-$21,018
Form type
4
Date filed
11/16/2022, 04:10 PM
Previous filing
Oct 26, 2022
Next filing
Jan 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale -$21K -2.36K -1.22% $8.91 190K Nov 14, 2022 See Footnote F1, F2, F3
holding ALVR Common Stock 249K Nov 14, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 26, 2022.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.90 to $8.94. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 Shares held by The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.